Sökning: "Biomedicine"
Visar resultat 21 - 25 av 109 avhandlingar innehållade ordet Biomedicine.
21. Characterisation of Neisseria meningitidis from a virulence and immunogenic perspective that includes variations in novel vaccine antigens
Sammanfattning : Neisseria meningitidis, also referred to as meningococcus, is a Gram-negative diplococcal bacterium best known as an important cause of meningitis and septicaemia worldwide. Meningococcal disease is a rare but life-threatening illness that may progress to death despite optimal medical care including appropriate antibiotic therapy. LÄS MER
22. Inflammation in atherosclerosis
Sammanfattning : Consequences of atherosclerosis may result in a number of diseases of the cardiovascular system that represent serious health problems and major causes of morbidity and mortality worldwide. Although it is initially considered as disease of fibro-lipid and thrombus deposition in the arterial wall, it also involves an ongoing inflammatory response. LÄS MER
23. Monocyte and Neutrophil Inflammatory Responses to the Periodontopathogen Porphyromonas gingivalis
Sammanfattning : Periodontitis is one of the most common adult infections. Duing bacteremia in healthy individuals or patients with chronic periodontitis, a number of oral bacteria such as Porphyromonas gingivalis encounter inflammatory cells in the blood eg. platelets, neutrophils and monocytes. LÄS MER
24. Amino acid transport and receptor binding properties in neuropsychiatric disorders using the fibroblast cell model
Sammanfattning : Altered transport of the catecholamines and serotonin precursor amino acids tyrosine and tryptophan, might be one explanation for the dysfunctional neurotransmission implicated in the pathophysiology of bipolar disorder and Attention Deficit/Hyperactivity Disorder (ADHD). In previous studies, an altered amino acid transport has been found in schizophrenia and autism, when using the fibroblast cell model. LÄS MER
25. Managing the Effect of Manufacturing Variation in Medical Treatments
Sammanfattning : To stay competitive in the market today, biomedical manufacturing companies must shorten their product realization time. These companies also deal with an increased demand for medical applications of high quality, from both the perspectives of user, government and internal requirements. LÄS MER